The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

The Philadelphia College of Pharmacy was the first pharmacy college in North America. And for 30 years, the historic ...

Manufacturing in Ireland has long helped many American drug companies pay lower taxes. But that strategy was designed for a ...

Thursday, August 14, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including Merck & Co.

For the second year running, New Jersey's Merck tops the list of responsible companies, highlighting a strong commitment to sustainability and social responsibility among local firms.

Merck & Co, a leading healthcare giant, has seen its shares plummet by 30% over the past year. Investors generally view the ...

Dividend investing is gaining popularity as more Americans turn to secondary income sources to offset market volatility and ...

The pivotal Phase 3 trial for Cylembio® in advanced melanoma showed clinical improvement in progression free survival, but missed its primary endpoint for statistical significance (p=0.056; threshold ...

The first half of 2025 has seen an acceleration of M&A activity, including large-scale life sciences transactions, such as Merck’s $3.9 ...

The company will instead focus resources on its last remaining clinical asset, PRT7732, a chemically distinct SMARCA2 degrader.

The directive calls for building a six-month Strategic Active Pharmaceutical Ingredients Reserve, updating the essential ...